Cargando…

The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity

We have shown that melanoma-derived factors alter the function of differentiated tissue-resident dendritic cells (DC) in a tumorigenicity-dependent manner. Soluble factors, including TGFβ1 and VEGF-A, contributed to dendritic cell dysfunction associated with a highly-aggressive melanoma and conferre...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hargadon, Kristian Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760289/ https://www.ncbi.nlm.nih.gov/pubmed/26942090 http://dx.doi.org/10.1080/2162402X.2015.1069462

Ejemplares similares

Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
por: Gerlini, Gianni, et al.
Publicado: (2012)

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014)

Tumorigenic de-differentiation: the alternative splicing way
por: Ray, Debleena, et al.
Publicado: (2020)

Regulation of tumorigenic splicing by protein condensates with specific biophysical properties
por: Li, Wei, et al.
Publicado: (2020)

BRAF-targeted therapy alters the functions of intratumoral CD4(+) T cells to inhibit melanoma progression
por: Ho, Ping-Chih, et al.
Publicado: (2014)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
por: Michielsen, Adriana J., et al.
Publicado: (2012)

Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments
por: Jinushi, Masahisa
Publicado: (2014)

Tissue-resident memory T cells in immune-related adverse events: friend or foe?
por: Reschke, Robin, et al.
Publicado: (2023)

Identification of human tissue cross-presenting dendritic cells: A new target for cancer vaccines
por: Haniffa, Muzlifah, et al.
Publicado: (2013)

Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells
por: Larmonier, Nicolas, et al.
Publicado: (2012)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

Identification of human inflammatory dendritic cells
por: Segura, Elodie, et al.
Publicado: (2013)

IL-10 control of dendritic cells in the skin
por: Clausen, Björn E., et al.
Publicado: (2013)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Activation of dendritic cells by tumor cell death
por: Cirone, Mara, et al.
Publicado: (2012)

Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
por: Hargadon, Kristian M.
Publicado: (2013)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Zoledronate-pulsed dendritic cell-based anticancer vaccines
por: Kamigaki, Takashi, et al.
Publicado: (2013)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Melanoma metastases caught in the AKT
por: Kircher, David A., et al.
Publicado: (2016)

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
por: Hargadon, Kristian M.
Publicado: (2017)

TGFβ1 microenvironment determines dendritic cell development
por: Seré, Kristin, et al.
Publicado: (2013)

Dendritic cell-based vaccines: Shining the spotlight on signal 3
por: Linette, Gerald P, et al.
Publicado: (2013)

Disarmed by density: A glycolytic break for immunostimulatory dendritic cells?
por: Nasi, Aikaterini, et al.
Publicado: (2013)

How imiquimod licenses plasmacytoid dendritic cells to kill tumors
por: Holcmann, Martin, et al.
Publicado: (2012)

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Role of plasmacytoid dendritic cells in breast cancer bone dissemination
por: Sawant, Anandi, et al.
Publicado: (2013)

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
por: Labidi-Galy, Sana Intidhar, et al.
Publicado: (2012)

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
por: Schreibelt, Gerty, et al.
Publicado: (2013)

Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013)

CD56 marks human dendritic cell subsets with cytotoxic potential
por: Roothans, Dessie, et al.
Publicado: (2013)

Whole Genome Expression Microarray Analysis of Highly Versus Poorly Tumorigenic Murine Melanoma Cell Lines Provides Insights into Factors That Regulate Tumor Growth, Metastasis, and Immunogenicity
por: Hargadon, Kristian Michael
Publicado: (2015)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

Disseminating melanoma cells surf on calcium waves
por: Sun, Jianwei, et al.
Publicado: (2015)

FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012)

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)

Is there a future for adoptive cell transfer in melanoma patients?
por: Besser, Michal J
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pdb5a6otm42qt3if1pc8j9a96n